ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Survival Outcomes of Kidney Transplant Recipients from Expanded Criteria Donors: A Systematic Review and Meta-Analysis

    A.-H. Querard,1,2,3 F. Gillaizeau,1,3 Y. Foucher,1,3 E. Dantan,3 D. Larmet,1 M. Lorent,3 L.-M. Pouteau,1 C. Combescure,4 M. Giral.1,3,5

    1Institute for Transplantation, Urology and Nephrology, CHU Nantes, Inserm U1064, Nantes University, Nantes, France; 2Centre Hospitalier Départemental de Vendée, La Roche sur Yon, France; 3EA 4275 SPHERE-bioStatistics, Pharmacoepidemiology and Human sciEnces REsearch, Nantes University, Nantes, France; 4CRC & Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva, Geneva, Switzerland; 5LabExTransplantex Nantes, Centre d'Investigation Clinique Biothérapie, Nantes, France.

    Background: In 2002, UNOS proposed the use of Expanded Criteria Donors (ECD=brain dead donor > 60 years, or 50-59 years with two criteria: CVA as…
  • 2015 American Transplant Congress

    Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records

    T. Kou,1 A. Deshmukh,1 J. Preston,1 A. Gomez,1 S. Rafanelli,2 K. Calderon.1

    1Bristol-Myers Squibb Company, Princeton, NJ; 2BiologicTx, Totowa, NJ.

    Purpose: Belatacept is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant in combination with basiliximab…
  • 2015 American Transplant Congress

    Efficacy of Rituximab Sparing Protocol for ABO Incompatible Renal Transplant in Patients With Low Titers

    S. Narumi,1 Y. Watarai,1 N. Goto,1 T. Hiramitsu,1 T. Yamamoto,1 M. Tsujita,1 M. Okada,1 K. Futamura,1 A. Takeda,2 T. Kobayashi.3

    1Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 2Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan; 3Applied Immunology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

    [Introduction]Acute antibody mediated rejection (AMR) has been a major problem in ABO-incompatible kidney transplantation (ABOi-KTx), and currently mycophenolate mofetil and rituximab have been used to…
  • 2015 American Transplant Congress

    The Impact of CDC High Risk Donors on Patient and Graft Survival After Liver Transplantation

    D. Moonka, A. Yoshida, A. Taylor.

    Division of Gastroenterology, Henry Ford Health System, Detroit, MI; Transplant Institute, Henry Ford Health System, Detroit, MI; Department of Public Health Sciences, Henry Ford Health System, Detroit, MI.

    We hypothesized that CDC high risk donors (HRD) might be younger than non-HRD and have other characteristics associated with favorable outcomes after liver transplant (LT).…
  • 2015 American Transplant Congress

    Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report

    M. Asolati,1 C. Kulig,2 B. Bilir,2 T. Pillen,1 P. Gauthier,2 B. Bista,2 T. Heffron.1

    1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO.

    INTRODUCTION: Discrepancy between demand (end stage organ disease) and supply (organs) remains one of the limiting factors in solid organ transplantation and underlies the dynamics…
  • 2015 American Transplant Congress

    Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes

    T. Joson, T. Schiano, A. Mehrotra.

    Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    Vitamin D is known to be immunomodulatory, and its deficiency is associated with multiple chronic health problems in the general population. The objective of this…
  • 2015 American Transplant Congress

    Age Should Not Be Considered a Contraindication for Living Kidney Donation

    D.-A. Moutzouris, R. Charif, J. Galliford, J. McDermott, H. Dulku, H. Orr, D. Taube, M. Loucaidou.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    The increasing numbers of patients with ESRD on the transplant waiting list has been the main driving force for expanding the donor pool. Acceptance of…
  • 2015 American Transplant Congress

    The Effect of Changing Candidate Demographics on Living Donor Kidney Transplant Rates

    G. Vranic, A. Nishio Lucar, D. Keith.

    Medicine, University of Virginia, Charlottesville, VA.

    Living donor (LD) rates continue to decline despite a growing list of candidates for renal transplant in the US. While there are many factors driving…
  • 2015 American Transplant Congress

    The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes

    A. Malone,1 D. Brennan,1 J. Wellen,2 T. Alhamad.1

    1Transplantation Nephrology, Renal Division, Washington University, St Louis; 2Section of Transplant Surgery, Washington University, St Louis.

    Background: Pancreas transplantation is associated with a high incidence of surgical complications and successful outcomes require experienced surgical and post-transplant care. Prior studies have linked…
  • 2015 American Transplant Congress

    Do Induction Therapy, Patient-Level and Post-Operative Factors Impact Outcomes in Moderate to High Immunologic Risk Simultaneous Kidney-Pancreas Transplantation in the Era of Stringent HLA Cross-Matching?

    V. Rohan, D. Taber, D. Taraskiewicz, S. Nadig, J. Mcgillicuddy, K. Chavin, P. Baliga, C. Bratton.

    MUSC, Charleston, SC.

    Background: Simultaneous kidney and pancreas transplantation (SPK) is a lifesaving procedure for patients with diabetes mellitus. The success of SPK is dependent upon minimization of…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences